Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.
Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe website has added a new intervention type and updated the status of a verified intervention by David Minor, MD, while removing the previous intervention type from the earlier revision.SummaryDifference1.0%
- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check41 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check56 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference4%
- Check63 days agoChange DetectedSeveral key health-related links have been removed, including those related to melanoma and various rare diseases, which may impact access to important medical information.SummaryDifference0.7%
- Check70 days agoChange DetectedThe website has been updated to version 2.12.2, with new additions including links to various medical resources related to melanoma and rare diseases, as well as treatment information for Yttrium, Ipilimumab, and Nivolumab.SummaryDifference5%
Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.